baltimore conference logo
  • MJHLS Brand Logo

© 2021 MJH Life Sciences™ , Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways. All rights reserved.

The Challenges of Treating Follicular Cell-Derived Thyroid Carcinoma

January 28, 2015
Keith C. Bible, MD, PhD

Special Reports, Head and Neck Cancers (Issue 3), Volume 3, Issue 1

Keith C. Bible, MD, PhD, professor of oncology, Mayo Clinic, discusses the challenges associated with treating patients with follicular cell-derived thyroid carcinoma.

Keith C. Bible, MD, PhD, professor of oncology, Mayo Clinic, discusses the challenges associated with treating patients with follicular cell-derived thyroid carcinoma.

<<<

Back to the Head & Neck Cancers Special Report